Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Development of Blood Vessels01:07

Development of Blood Vessels

1.1K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disparities in Diagnostic Yield of Genetic Testing in Children and Adolescents With Vascular Malformations and/or Overgrowth: A Single Site Experience.

American journal of medical genetics. Part A·2026
Same author

Health-Related Quality of Life and Symptom Severity Among Patients With PIK3CA-Related Overgrowth Spectrum: A Mixed-Methods Study to Understand Real-World Experience With Alpelisib Treatment.

Pediatric blood & cancer·2026
Same author

Somatic Genetic Testing Provides Diagnosis of Verrucous Venous Malformation in an Individual with Discrepant Radiology, Pathology, and Clinical Findings.

Journal of vascular anomalies·2026
Same author

Impact of anticoagulation on quality of life in patients with slow-flow vascular malformations.

Blood vessels, thrombosis & hemostasis·2025
Same author

Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.

JAMA·2025
Same author

Visualizing Genetics: An Investigation of Dermoscopy as a Tool for Genetic Variant Prediction in Capillary Malformations.

Pediatric dermatology·2025

Related Experiment Video

Updated: Nov 17, 2025

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.5K

Neonatal Vascular Tumors.

Michael Briones1, Denise Adams2

  • 1Pediatric Hematology and Oncology, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, USA.

Clinics in Perinatology
|February 15, 2021
PubMed
Summary
This summary is machine-generated.

This review covers neonatal vascular tumors, distinguishing them from malformations. It highlights diagnostic challenges and summarizes treatment options for these proliferative lesions.

Keywords:
CongenitalMultidisciplinaryNeonateVascular anomalyVascular tumors

More Related Videos

Neonatal Subventricular Zone Electroporation
08:06

Neonatal Subventricular Zone Electroporation

Published on: February 11, 2013

13.1K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.2K

Related Experiment Videos

Last Updated: Nov 17, 2025

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.5K
Neonatal Subventricular Zone Electroporation
08:06

Neonatal Subventricular Zone Electroporation

Published on: February 11, 2013

13.1K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.2K

Area of Science:

  • Pediatric Oncology
  • Dermatology
  • Vascular Biology

Background:

  • Vascular tumors are proliferative lesions within the vascular anomalies spectrum.
  • Distinguishing tumors from malformations is crucial due to differing biology and management.
  • Neonatal vascular lesions present unique diagnostic and therapeutic challenges.

Purpose of the Study:

  • To provide an overview of vascular tumors in the neonatal period.
  • To differentiate vascular tumors from vascular malformations.
  • To summarize current treatment strategies for neonatal vascular tumors.

Main Methods:

  • Literature review focusing on neonatal vascular tumors.
  • Analysis of diagnostic criteria for various vascular tumors.
  • Synthesis of treatment modalities based on tumor type and clinical presentation.

Main Results:

  • Vascular tumors are characterized by proliferation, unlike low-turnover malformations.
  • Infantile hemangioma is common and often clinically diagnosed.
  • Rare neonatal vascular tumors pose diagnostic and therapeutic difficulties.

Conclusions:

  • Accurate differential diagnosis is essential for appropriate management of neonatal vascular tumors.
  • Treatment approaches vary widely, from observation to complex interventions.
  • Further research is needed for optimal management of rare neonatal vascular tumors.